Biogen
BIIB
BIIB
1,100 hedge funds and large institutions have $43.4B invested in Biogen in 2021 Q2 according to their latest regulatory filings, with 134 funds opening new positions, 323 increasing their positions, 467 reducing their positions, and 110 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.18% less ownership
Funds ownership: 83.72% → 83.55% (-0.18%)
6% less call options, than puts
Call options by funds: $1.8B | Put options by funds: $1.91B
31% less repeat investments, than reductions
Existing positions increased: 323 | Existing positions reduced: 467
Holders
1,100
Holding in Top 10
27
Calls
$1.8B
Puts
$1.91B
Top Buyers
| 1 | +$508M | |
| 2 | +$169M | |
| 3 | +$130M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$115M |
| 5 |
HM
HealthCor Management
New York
|
+$89.6M |
Top Sellers
| 1 | -$211M | |
| 2 | -$195M | |
| 3 | -$193M | |
| 4 |
Berkshire Hathaway
Omaha,
Nebraska
|
-$180M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$176M |